|
Tuesday, 06 January 2009 |
|
Drug Trials Individuals who have persistent high blood pressure are at increased risks of many serious medical conditions, including heart failure.One of the factors that contributes to such heart failure is thickening of the muscle wall of the heart. |
|
Read more...
|
|
|
Friday, 02 January 2009 |
|
Pharmaceutical News Daiichi Sankyo Company, Limited and Eli Lilly and Company has affirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) will review prasugrel during an advisory committee hearing on February 3, 2009. |
|
Read more...
|
|
|
Monday, 29 December 2008 |
|
Disease/Infection News A infrequent flesh-eating disease has claimed the life of a man in Britain. The 60 year old man Tony Williamson died days after a flesh-eating disease spread through his body from a little cut on the inside of his right arm. |
|
Read more...
|
|
|
Monday, 22 December 2008 |
|
Disease/Infection News Amorfix Life Sciences has announced it achieved 100% sensitivity and 100% specificity in a second blinded trial of human blood samples using its EP-vCJD blood test in collaboration with the National Institute for Biological Standards and Control (NIBSC) in the United Kingdom. |
|
Read more...
|
|
|
Monday, 22 December 2008 |
|
Drug Trials The University of California, San Diego Medical Center is the first hospital in California to enroll patients in a multi-center clinical trial, sponsored by Angioblast Systems Inc. |
|
Read more...
|
|
|
Saturday, 20 December 2008 |
|
Medical Research News Two general biomarkers have now been shown to advance the capability to predict who will suffer from a stroke. |
|
Read more...
|
|
|
Thursday, 18 December 2008 |
|
Medical Condition News For kidney disease patients who need to undergo dialysis, one type of treatment is not best for all, according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology (JASN). |
|
Read more...
|
|
|
Thursday, 18 December 2008 |
|
Drug Trials Biopure Corporation has announced that it has submitted to the Food and Drug Administration (FDA) an investigational new drug (IND) application to conduct a pilot phase 2 clinical trial of the company's oxygen therapeutic Hemopure [hemoglobin glutamer - 250 (bovine)]. |
|
Read more...
|
|
|
Tuesday, 16 December 2008 |
|
Medical Research News Van Andel Institute (VAI) researchers are the first to use a new technology to measure on a large scale the presence of genes in blood spots - the blood drawn from newborn infants to screen for health-threatening conditions. |
|
Read more...
|
|
|
Tuesday, 16 December 2008 |
|
Devices/Technology A carbon nanotube-coated "smart yarn" that conducts electricity could be woven into soft fabrics that detect blood and monitor health, engineers at the University of Michigan have demonstrated."Currently, smart textiles are made primarily of metallic or optical fibers. |
|
Read more...
|
|
|
Monday, 15 December 2008 |
|
Medical Research News Researchers at Johns Hopkins have shown that brain damage was decreased by as much as 62.2 percent in mice who inhale low amounts of carbon monoxide after an induced stroke.The scientists, in a report published online Dec. |
|
Read more...
|
|
|
Thursday, 11 December 2008 |
|
Medical Research News For patients with moderate chronic kidney disease (CKD), higher levels of phosphorus in the blood are associated with increased calcification of the major arteries and heart valves - which may contribute to the increased risk of cardiovascular disease in patients with CKD,... |
|
Read more...
|
|
|
Wednesday, 10 December 2008 |
|
Medical Research News For the first time, researchers have found that a modified form of a naturally happening protein, N-cadherin, could prevent blocked arteries. Blocked arteries are a major cause of heart attacks and strokes. |
|
Read more...
|
|
|
Tuesday, 09 December 2008 |
|
Drug Trials Pregnancy and surgery patients with a serious blood disorder that causes excessive clotting have responded well to treatment with a man-made anti-clotting protein. |
|
Read more...
|
|
|
Monday, 08 December 2008 |
|
Drug Trials Daiichi Sankyo Company, Limited, has announced that it has initiated its pivotal Phase III trial for DU-176b, an investigational oral Factor Xa inhibitor, in patients with atrial fibrillation. DU-176b is being developed only by Daiichi Sankyo. |
|
Read more...
|
|
|
Friday, 05 December 2008 |
|
Medical Research News A medication used for high blood pressure does not enhance a regular form of heart failure, according to new results from a large, international study. |
|
Read more...
|
|
|
Thursday, 04 December 2008 |
|
Medical Condition News New guidelines developed by the American Academy of Neurology find a combination of blood tests and other specialized assessments appear to be the most useful tests for finding the cause of neuropathy. |
|
Read more...
|
|
|
Tuesday, 02 December 2008 |
|
Medical Research News If you think your levels of "valuable cholesterol" are valuable enough, a new study published in the December 2008 issue of The FASEB Journal suggests that you may desire to think again. |
|
Read more...
|
|
|
Monday, 01 December 2008 |
|
Disease/Infection News Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology, and the University of Edinburgh have uncovered how a bacterial pathogen interacts with the blood coagulation protein fibrinogen to cause methicillin-resistant Staphylococcus aureus... |
|
Read more...
|
|
|
Wednesday, 26 November 2008 |
|
Medical Research News Sickle cell anaemia is a genetic disease characterised by the sickling of red blood cells in patients suffering from hypoxia (around 100,000 cases in Europe and North America). |
|
Read more...
|
|
|
Tuesday, 25 November 2008 |
|
|
|
Read more...
|
|
|
Monday, 24 November 2008 |
|
Medical Condition News Many patients with cardiovascular disease are not given adequate drug therapy.This is the result of an international study. |
|
Read more...
|
|
|
Sunday, 23 November 2008 |
|
Medical Research News Scientists from the Scripps Research Institute have discovered the key chemical that signals Bacillus anthracis, the bacterium that causes anthrax, to become lethal.This finding opens up new avenues of exploration for the development of treatments for bacterial infections. |
|
Read more...
|
|
|
Friday, 21 November 2008 |
|
Medical Research News A team of researchers at Duke University Medical Center and the University Catholique de Louvain (UCL) has found that lactic acid is an significant energy source for tumor cells. |
|
Read more...
|
|
|
Monday, 17 November 2008 |
|
Medical Research News Healthy adults with higher levels of phosphate in the blood are more likely to have increased levels of calcium in the coronary arteries-a key indicator of atherosclerosis and future cardiovascular disease risk, reports a study in the February 2009 issue of the Journal of the... |
|
Read more...
|
|
|
Friday, 14 November 2008 |
|
Medical Condition News Investigators at Children's Research Institute, BloodCenter of Wisconsin's Blood Research Institute and the Medical College of Wisconsin have discovered a new way to help the blood clot by having the missing clotting cause packaged in the patient's own platelets. |
|
Read more...
|
|
|
Thursday, 13 November 2008 |
|
Medical Procedure News Heart experts at Johns Hopkins have evidence that life-saving coronary angioplasty at community hospitals is safer when physicians and hospital staff have more experience with the procedure.In a report to be presented Nov. |
|
Read more...
|
|
|
Thursday, 13 November 2008 |
|
Drug Trials NicOx S.A. has announced that a new study of the data from the 104 Ambulatory Blood Pressure Monitoring (ABPM) study for naproxcinod was presented yesterday at the American Heart Association Scientific Sessions 2008, in New Orleans, USA. |
|
Read more...
|
|
|
Thursday, 13 November 2008 |
|
Medical Condition News More than half of people diagnosed with high blood pressure do not have it under control and many more go undiagnosed, according to research carried out at the University of Warwick. |
|
Read more...
|
|
|
Thursday, 13 November 2008 |
|
Medical Research News Blood levels of resistin, a hormone created by fat cells, can independently predict an individual's risk of heart failure, cardiologists at Emory University School of Medicine have found.Their findings were presented Nov. |
|
Read more...
|
|
